Aerpio Pharmaceuticals, Inc.

ARPO · NASDAQ
Analyze with AI
12/31/2024
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$28,670$14,852$10,288$9,649
Short-Term Investments$18,567$0$0$0
Receivables$5,903$0$0$0
Inventory$5,311$0$0$0
Other Curr. Assets$2,836$12,195$4,707$1,197
Total Curr. Assets$61,287$27,047$14,995$10,846
Property Plant & Equip (Net)$7,633$46,652$38,072$12,837
Goodwill$0$3,490$3,490$3,490
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,399-$50,142-$41,562-$16,327
Total NC Assets$9,032$50,142$41,562$16,327
Other Assets$0$18,645$13,211$12,343
Total Assets$70,319$95,834$69,768$39,516
Liabilities
Payables$2,159$1,678$1,138$956
Short-Term Debt$268$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$14,647$23,195$3,676$5,749
Total Curr. Liab.$17,074$24,873$4,814$6,705
LT Debt$565$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$202$0$0$0
Total NC Liab.$767$0$0$0
Other Liabilities$0$31,804$36,480$10,877
Cap. Leases$0$0$0$0
Total Liabilities$17,841$59,754$44,371$20,659
Equity
Pref Stock$0$0$0$0
Common Stock$2$361$271$187
Retained Earnings-$332,654-$239,774-$202,857-$179,702
AOCI$16$0$0$0
Other Equity$385,114$275,493$227,983$198,372
Total Equity$52,478$36,080$25,397$18,857
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$70,319$95,834$69,768$39,516
Net Debt-$27,837-$14,852-$10,288-$9,649